CI logo

Cigna (CI) EBITDA

annual EBITDA:

$9.48B-$515.00M(-5.15%)
December 31, 2024

Summary

  • As of today (May 29, 2025), CI annual EBITDA is $9.48 billion, with the most recent change of -$515.00 million (-5.15%) on December 31, 2024.
  • During the last 3 years, CI annual EBITDA has fallen by -$1.44 billion (-13.20%).
  • CI annual EBITDA is now -37.26% below its all-time high of $15.11 billion, reached on December 31, 2020.

Performance

CI EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCIincome statement metrics

quarterly EBITDA:

$2.68B-$333.00M(-11.04%)
March 31, 2025

Summary

  • As of today (May 29, 2025), CI quarterly EBITDA is $2.68 billion, with the most recent change of -$333.00 million (-11.04%) on March 31, 2025.
  • Over the past year, CI quarterly EBITDA has increased by +$1.54 billion (+135.03%).
  • CI quarterly EBITDA is now -58.25% below its all-time high of $6.43 billion, reached on December 31, 2020.

Performance

CI quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCIincome statement metrics

TTM EBITDA:

$11.02B+$1.54B(+16.27%)
March 31, 2025

Summary

  • As of today (May 29, 2025), CI TTM EBITDA is $11.02 billion, with the most recent change of +$1.54 billion (+16.27%) on March 31, 2025.
  • Over the past year, CI TTM EBITDA has increased by +$2.59 billion (+30.77%).
  • CI TTM EBITDA is now -27.35% below its all-time high of $15.17 billion, reached on March 31, 2021.

Performance

CI TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCIincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

CI EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-5.2%+135.0%+30.8%
3 y3 years-13.2%+3.9%+0.5%
5 y5 years-20.4%+8.2%-2.0%

CI EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-24.5%at low-40.6%+135.0%-13.1%+41.8%
5 y5-year-37.3%at low-58.3%+135.0%-27.4%+41.8%
alltimeall time-37.3%+4294.3%-58.3%+331.4%-27.4%+1201.0%

CI EBITDA History

DateAnnualQuarterlyTTM
Mar 2025
-
$2.68B(-11.0%)
$11.02B(+16.3%)
Dec 2024
$9.48B(-5.2%)
$3.02B(+36.0%)
$9.48B(+21.9%)
Sep 2024
-
$2.22B(-28.5%)
$7.78B(-8.8%)
Jun 2024
-
$3.10B(+171.6%)
$8.53B(+1.2%)
Mar 2024
-
$1.14B(-13.0%)
$8.43B(-15.7%)
Dec 2023
$9.99B(-20.4%)
$1.31B(-55.8%)
$9.99B(-9.9%)
Sep 2023
-
$2.97B(-1.0%)
$11.10B(-12.3%)
Jun 2023
-
$3.00B(+10.9%)
$12.65B(-0.3%)
Mar 2023
-
$2.71B(+12.0%)
$12.69B(+1.0%)
Dec 2022
$12.56B(+15.0%)
$2.42B(-46.5%)
$12.56B(+0.5%)
Sep 2022
-
$4.52B(+48.7%)
$12.50B(+12.9%)
Jun 2022
-
$3.04B(+17.7%)
$11.08B(+1.0%)
Mar 2022
-
$2.58B(+9.6%)
$10.96B(+0.4%)
Dec 2021
$10.92B(-27.7%)
$2.36B(-23.9%)
$10.92B(-27.2%)
Sep 2021
-
$3.10B(+5.8%)
$14.99B(+1.7%)
Jun 2021
-
$2.93B(+15.1%)
$14.74B(-2.8%)
Mar 2021
-
$2.54B(-60.5%)
$15.17B(+0.4%)
Dec 2020
$15.11B(+26.9%)
$6.43B(+126.2%)
$15.11B(+34.2%)
Sep 2020
-
$2.84B(-15.3%)
$11.26B(-2.1%)
Jun 2020
-
$3.36B(+35.3%)
$11.50B(+2.3%)
Mar 2020
-
$2.48B(-3.8%)
$11.25B(-5.5%)
Dec 2019
$11.90B(+149.3%)
$2.58B(-16.5%)
$11.90B(+17.9%)
Sep 2019
-
$3.09B(-0.4%)
$10.10B(+21.6%)
Jun 2019
-
$3.10B(-1.2%)
$8.30B(+27.8%)
Mar 2019
-
$3.14B(+306.9%)
$6.50B(+36.1%)
Dec 2018
$4.77B(+7.9%)
$771.00M(-40.4%)
$4.77B(-2.6%)
Sep 2018
-
$1.29B(0.0%)
$4.90B(+7.2%)
Jun 2018
-
$1.29B(-8.6%)
$4.57B(+0.4%)
Mar 2018
-
$1.42B(+57.4%)
$4.55B(+9.1%)
Dec 2017
$4.42B(+14.4%)
$899.00M(-6.6%)
$4.17B(+3.6%)
Sep 2017
-
$963.00M(-24.4%)
$4.03B(+1.8%)
Jun 2017
-
$1.27B(+23.0%)
$3.96B(+8.5%)
Mar 2017
-
$1.04B(+37.2%)
$3.65B(+1.6%)
Dec 2016
$3.87B(-1.2%)
$755.00M(-15.4%)
$3.59B(-1.0%)
Sep 2016
-
$892.00M(-7.6%)
$3.63B(-3.6%)
Jun 2016
-
$965.00M(-1.2%)
$3.76B(-3.1%)
Mar 2016
-
$977.00M(+23.2%)
$3.88B(-0.7%)
Dec 2015
$3.91B(+0.5%)
$793.00M(-22.8%)
$3.91B(-2.3%)
Sep 2015
-
$1.03B(-5.5%)
$4.00B(+1.6%)
Jun 2015
-
$1.09B(+8.2%)
$3.94B(+1.2%)
Mar 2015
-
$1.00B(+13.6%)
$3.89B(+0.1%)
Dec 2014
$3.89B(+40.4%)
$885.00M(-8.2%)
$3.89B(+5.3%)
Sep 2014
-
$964.00M(-7.3%)
$3.69B(+0.5%)
Jun 2014
-
$1.04B(+3.7%)
$3.68B(+3.5%)
Mar 2014
-
$1.00B(+45.8%)
$3.55B(+28.1%)
Dec 2013
$2.77B(-8.7%)
$688.00M(-27.2%)
$2.77B(-3.0%)
Sep 2013
-
$945.00M(+3.2%)
$2.86B(+3.3%)
Jun 2013
-
$916.00M(+308.9%)
$2.77B(+7.1%)
Mar 2013
-
$224.00M(-71.0%)
$2.58B(-14.9%)
Dec 2012
$3.04B(+36.7%)
$773.00M(-9.5%)
$3.04B(+8.9%)
Sep 2012
-
$854.00M(+16.7%)
$2.79B(+21.6%)
Jun 2012
-
$732.00M(+8.0%)
$2.29B(+0.4%)
Mar 2012
-
$678.00M(+29.1%)
$2.29B(-1.2%)
Dec 2011
$2.22B
$525.00M(+46.2%)
$2.31B(-1.7%)
Sep 2011
-
$359.00M(-50.3%)
$2.35B(-8.8%)
Jun 2011
-
$723.00M(+2.4%)
$2.58B(+5.3%)
DateAnnualQuarterlyTTM
Mar 2011
-
$706.00M(+25.0%)
$2.45B(+10.0%)
Dec 2010
$2.09B(-10.2%)
$565.00M(-3.7%)
$2.23B(-0.2%)
Sep 2010
-
$587.00M(-1.2%)
$2.23B(+1.7%)
Jun 2010
-
$594.00M(+23.0%)
$2.19B(-4.9%)
Mar 2010
-
$483.00M(-15.1%)
$2.31B(+6.5%)
Dec 2009
$2.33B(+272.5%)
$569.00M(+3.6%)
$2.17B(+63.8%)
Sep 2009
-
$549.00M(-22.2%)
$1.32B(+23.6%)
Jun 2009
-
$706.00M(+106.4%)
$1.07B(+27.2%)
Mar 2009
-
$342.00M(-224.4%)
$841.00M(+34.3%)
Dec 2008
$626.00M(-65.7%)
-$275.00M(-192.6%)
$626.00M(-53.1%)
Sep 2008
-
$297.00M(-37.7%)
$1.34B(-16.0%)
Jun 2008
-
$477.00M(+275.6%)
$1.59B(+7.1%)
Mar 2008
-
$127.00M(-70.8%)
$1.49B(-18.6%)
Dec 2007
$1.82B(-5.9%)
$435.00M(-21.1%)
$1.82B(+1.8%)
Sep 2007
-
$551.00M(+48.1%)
$1.79B(+3.3%)
Jun 2007
-
$372.00M(-20.3%)
$1.74B(-4.9%)
Mar 2007
-
$467.00M(+16.2%)
$1.82B(-5.9%)
Dec 2006
$1.94B(-3.7%)
$402.00M(-18.6%)
$1.94B(+2.3%)
Sep 2006
-
$494.00M(+7.2%)
$1.90B(+2.9%)
Jun 2006
-
$461.00M(-20.8%)
$1.84B(-1.4%)
Mar 2006
-
$582.00M(+62.1%)
$1.87B(-7.2%)
Dec 2005
$2.01B(-22.7%)
$359.00M(-18.6%)
$2.01B(-20.1%)
Sep 2005
-
$441.00M(-9.4%)
$2.52B(-4.4%)
Jun 2005
-
$487.00M(-33.0%)
$2.63B(-10.9%)
Mar 2005
-
$727.00M(-16.0%)
$2.96B(+13.6%)
Dec 2004
$2.60B(+138.1%)
$865.00M(+55.6%)
$2.60B(+20.5%)
Sep 2004
-
$556.00M(-31.4%)
$2.16B(+10.5%)
Jun 2004
-
$810.00M(+116.6%)
$1.96B(+74.2%)
Mar 2004
-
$374.00M(-11.2%)
$1.12B(+2.7%)
Dec 2003
$1.09B(-584.1%)
$421.00M(+19.9%)
$1.09B(+49.2%)
Sep 2003
-
$351.00M(-1626.1%)
$733.00M(+67.4%)
Jun 2003
-
-$23.00M(-106.7%)
$438.00M(-13.1%)
Mar 2003
-
$345.00M(+475.0%)
$504.00M(+130.1%)
Dec 2002
-$226.00M(-196.2%)
$60.00M(+7.1%)
$219.00M(-121.9%)
Sep 2002
-
$56.00M(+30.2%)
-$1.00B(+72.0%)
Jun 2002
-
$43.00M(-28.3%)
-$582.00M(+216.3%)
Mar 2002
-
$60.00M(-105.2%)
-$184.00M(-178.3%)
Dec 2001
$235.00M(+6.3%)
-$1.16B(-344.2%)
$235.00M(-33.6%)
Sep 2001
-
$475.00M(+7.7%)
$354.00M(-1.7%)
Jun 2001
-
$441.00M(-7.9%)
$360.00M(+60.7%)
Mar 2001
-
$479.00M(-146.0%)
$224.00M(+1.4%)
Dec 2000
$221.00M(-84.7%)
-$1.04B(-316.4%)
$221.00M(-91.3%)
Sep 2000
-
$481.00M(+57.7%)
$2.53B(+19.1%)
Jun 2000
-
$305.00M(-35.9%)
$2.13B(+14.0%)
Mar 2000
-
$476.00M(-62.6%)
$1.86B(+29.2%)
Dec 1999
$1.44B(-30.4%)
$1.27B(+1618.9%)
$1.44B(-30.4%)
Sep 1999
-
$74.00M(+72.1%)
$2.08B(+0.4%)
Jun 1999
-
$43.00M(-21.8%)
$2.07B(+0.6%)
Mar 1999
-
$55.00M(-97.1%)
$2.05B(-1.1%)
Dec 1998
$2.08B(+1059.8%)
$1.90B(+2827.7%)
$2.08B(+489.8%)
Sep 1998
-
$65.00M(+116.7%)
$352.00M(+22.6%)
Jun 1998
-
$30.00M(-61.5%)
$287.00M(+41.4%)
Mar 1998
-
$78.00M(-56.4%)
$203.00M(+13.4%)
Dec 1997
$179.00M
$179.00M(-431.5%)
$179.00M(>+9900.0%)
Jun 1997
-
-$54.00M(-200.0%)
$0.00(-100.0%)
Mar 1997
-
$54.00M
$54.00M

FAQ

  • What is Cigna annual EBITDA?
  • What is the all time high annual EBITDA for Cigna?
  • What is Cigna annual EBITDA year-on-year change?
  • What is Cigna quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Cigna?
  • What is Cigna quarterly EBITDA year-on-year change?
  • What is Cigna TTM EBITDA?
  • What is the all time high TTM EBITDA for Cigna?
  • What is Cigna TTM EBITDA year-on-year change?

What is Cigna annual EBITDA?

The current annual EBITDA of CI is $9.48B

What is the all time high annual EBITDA for Cigna?

Cigna all-time high annual EBITDA is $15.11B

What is Cigna annual EBITDA year-on-year change?

Over the past year, CI annual EBITDA has changed by -$515.00M (-5.15%)

What is Cigna quarterly EBITDA?

The current quarterly EBITDA of CI is $2.68B

What is the all time high quarterly EBITDA for Cigna?

Cigna all-time high quarterly EBITDA is $6.43B

What is Cigna quarterly EBITDA year-on-year change?

Over the past year, CI quarterly EBITDA has changed by +$1.54B (+135.03%)

What is Cigna TTM EBITDA?

The current TTM EBITDA of CI is $11.02B

What is the all time high TTM EBITDA for Cigna?

Cigna all-time high TTM EBITDA is $15.17B

What is Cigna TTM EBITDA year-on-year change?

Over the past year, CI TTM EBITDA has changed by +$2.59B (+30.77%)
On this page